Risk of vaccine failure after Haemophilus influenzae type b (Hib) combination vaccines with acellular pertussis.
An increase in invasive Hib disease incidence in the UK has coincided with the distribution of combination vaccines that contain acellular pertussis (DTaP-Hib). These vaccines have been associated with reduced immunogenicity of the Hib component, although there is little agreement on the clinical relevance of this finding. We retrospectively compared vaccine formulations given to fully vaccinated Hib cases with those administered to fully immunised age-matched controls using conditional logistic regression. More cases than controls received all three doses of their infant primary course as DTaP-Hib, compared with two or three doses of another Hib vaccine (conditional odds ratio 6.77 [95% CI 3.26-14.07]).
Immunisation Division, Health Protection Agency Communicable Disease Surveillance Centre, Colindale, London, UK. jodie.mcvernon@hpa.org.uk <jodie.mcvernon@hpa.org.uk>
J
J
McVernon
N
N
Andrews
M P E
MP
Slack
M E
ME
Ramsay
D015721:Diphtheria-Tetanus-Pertussis Vaccine / Q000592:standards*; D018073:Haemophilus Vaccines / Q000592:standards*; D019741:Haemophilus influenzae type b; D017325:Hepatitis B Vaccines / Q000592:standards*; D006801:Humans; D007115:Immunization Schedule; D015994:Incidence; D007223:Infant; D008583:Meningitis, Haemophilus / Q000453:epidemiology* / Q000517:prevention & control; D012044:Regression Analysis; D012189:Retrospective Studies; D012307:Risk Factors; D017211:Treatment Failure; D006113:United Kingdom / Q000453:epidemiology
D015721:Diphtheria-Tetanus-Pertussis Vaccine; D018073:Haemophilus Vaccines; D017325:Hepatitis B Vaccines; C122182:diphtheria-tetanus-acellular pertussis-Hib-hepatitis B vaccine